In clinical research, the 60-day rule mandates that data must be submitted to regulatory agencies within 60 days of an event occurring in a trial. It’s crucial for maintaining compliance and ensuring participant safety, but many might not realize how significant this timeline is for both researchers and participants. What are some other regulations that you think are underappreciated in clinical trials?
I remember when we had to deal with the 60-day rule on a trial; it really kept everyone on their toes. One thing I’ve learned is to set reminders early in the process — those timelines sneak up fast. Have you seen how other regulations impact trial timelines?
The 60-day rule can indeed sneak up fast. In one trial, we found that scheduling bi-weekly check-ins helped us stay ahead of those deadlines. Agree it’s essential, but I’d also say having a centralized data management system can really streamline compliance. What strategies have you found useful?